Another vital discovery of our research was that we developed a cuproptosis-related prognostic signature containing six genes (CDKN2A, MTF1, PDHA1, DLD, LIPT1, and FDX1) for breast cancer, which predicted the OS rate with an accuracy that ranged from medium to high. Here, LIPT1 is linked to breast carcinoma.